PHARMACIST-LED medication reviews confer many benefits such as attainment of biomarker targets for improved clinical outcomes and other clinical parameters, as well as depict concrete financial advantages in terms of lowering total medication costs and associated savings, according to new work out of the UK and Malaysia.
An expert commentary on the study said, "The cost-effectiveness of medication reviews are more consequential than ever before.
"A critical evaluation of pharmacist-led medication reviews in residential aged care facilities from an economical aspect is crucial in determining if the time, effort, and direct and indirect costs involved in the review rationalise the significance of conducting medication reviews for older people in aged care facilities."
The research was published in the Journal Expert Review of Pharmacoeconomics & Outcomes Research.
Visit tandfonline.com for access.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Dec 17
